Search Results 1521-1530 of 17087 for First%2Baid

  1. A Study of Nab-Paclitaxel as Maintenance Treatment After Cisplatin-Based Chemotherapy and Surgery for Patients with High-Risk Bladder Cancer - Mayo Clinic

    There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent ...

  2. Combination Chemotherapy With or Without Temsirolimus in Treating Patients With Intermediate Risk Rhabdomyosarcoma - Mayo Clinic

    There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent ...

  3. A Study to Evaluate the Safety and Effectiveness of DCR-PHXC to Treat Patients with Primary Hyperoxaluria Type 1 or 2 and Severe Renal Impairment - Mayo Clinic

    There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent ...

  4. TAS-102 and Radiation Therapy in Treating Patients With Rectal Cancer That Is Locally Recurrent, Metastatic, or Cannot Be Removed by Surgery - Mayo Clinic

    There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent ...

  5. Study Of GI-102 And PD-1 In Glioblastoma - Mayo Clinic

    ... first dose of study drug. Pre-treatment testing. The following laboratory values obtained ≤15 days prior to registration: Hemoglobin ≥9.0 g/dL. Absolute ...

  6. Mouth cancer - Doctors and departments - Mayo Clinic

    Joseph Sirven, M.D., Professor of Neurology, Mayo Clinic: Mayo's mission is about the patient. The patient comes first. So the mission and research here is to ...

  7. Mouth cancer - Doctors and departments - Mayo Clinic

    Joseph Sirven, M.D., Professor of Neurology, Mayo Clinic: Mayo's mission is about the patient. The patient comes first. So the mission and research here is to ...

  8. Medical Research & Education - Mayo Clinic News Network

    First hybrid gene therapy shows early promise in treating long QT syndrome featured image. Individualized Medicine. First hybrid gene therapy shows early ...

  9. Medical Research & Education - Mayo Clinic News Network

    Early in his medical training, Sarosh Irani, B.M., B.Ch., D.Phil., met a patient who would change the course of his career. The woman, in her[...] ...

  10. Trigeminal neuralgia - Doctors and departments - Mayo Clinic

    Joseph Sirven, M.D., Professor of Neurology, Mayo Clinic: Mayo's mission is about the patient. The patient comes first. So the mission and research here is to ...